SCHEMBL1395802

SCHEMBL1395802

CC(=O)Nc1ccccc1C(F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.58
MAPK1 P28482 1/20 0.58
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 5/20 0.56
GAA P10253 2/20 0.55
TSHR P16473 1/20 0.55
LMNA P02545 1/20 0.55
HPGD P15428 2/20 0.55
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30136232 1.00 POLB (0.58) POLBMAPK1MEN1KMT2ASMN1; SMN2
Chloromethane SCHEMBL10795405 0.98 POLB (0.56) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL4554988 0.85 KMT2A (0.69) POLBMAPK1MEN1KMT2AKDM4E
SCHEMBL5540157 0.85 ALDH1A1 (0.52) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL3415036 0.85 RAB9A (0.58) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL5536288 0.84 ALDH1A1 (0.46) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL985910 0.84 TAS2R14 (0.57) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL12144664 0.84 EPHX2 (0.57) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL3938038 0.82 POLB (0.58) POLBMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL631133 0.82 ALDH1A1 (0.57) POLBMAPK1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961268-B1 SAMPLE FIXATION AND STABILISATION GOLDSBOROUGH ANDREW SIMON (FR) 2018-11-21 EP claimed
EP-2961268-A1 SAMPLE FIXATION AND STABILISATION Goldsborough, Andrew Simon (FR) 2016-01-06 EP claimed
US-20140295404-A1 SAMPLE FIXATION AND STABILISATION RNASSIST LTD. (GB) 2014-10-02 US claimed
WO-2014131906-A1 SAMPLE FIXATION AND STABILISATION GOLDSBOROUGH ANDREW SIMON (FR) 2014-09-04 WO claimed
JP-4665239-B2 2011-04-06 JP claimed
EP-0912492-B1 METHOD FOR PREPARING HALOGENATED 2-AMINO OR 2-ACETAMIDO TRIFLUOROMETHYLBENZENE DERIVATIVES RHODIA CHIMIE SA (FR) 2002-09-25 EP claimed
JP-2002512230-A 2002-04-23 JP claimed
US-6191309-B1 USING A COMPOUND OF FORMULA X2 IN A SOLVENT SELECTED FROM AN ANHYDROUS HALOGENATED HYDROCARBON, A MIXTURE OF WATER AND A HALOGENATED HYDROCARBON AND OPTIONALLY THE COMPOUND ITSELF, TO GIVE HALOGENATED 2-AMINO OR 2-ACETAMIDOTRIFLUOROMETHYLBENZENE RHODIA CHIMIE (FR) 2001-02-20 US claimed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP claimed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO claimed
EP-0912492-A1 METHOD FOR PREPARING HALOGENATED 2-AMINO OR 2-ACETAMIDO TRIFLUOROMETHYLBENZENE DERIVATIVES RHODIA CHIMIE (FR) 1999-05-06 EP claimed
WO-1998002409-A1 METHOD FOR PREPARING HALOGENATED 2-AMINO OR 2-ACETAMIDO TRIFLUOROMETHYLBENZENE DERIVATIVES RHODIA CHIMIE (FR) 1998-01-22 WO claimed
US-4008278-A FROM AN AMINO-BENZOTRIFLUORIDE AND A HALOGEN SOURCE OLIN CORPORATION (US) 1977-02-15 US claimed
WO-2025262036-A1 METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION RNASSIST LTD (GB) 2025-12-26 WO disclosed
EP-3827241-B1 DISSOCIATION OF BIOLOGICAL SAMPLES GOLDSBOROUGH ANDREW SIMON (FR) 2024-03-13 EP disclosed
US-20240027309-A1 SIMPLE FIXATION AND STABILISATION RNASSIST LTD (GB) 2024-01-25 US disclosed
EP-0143768-A1 Preparation of ortho-(alkylthiomethyl) anilines by catalytic sulfilimine rearrangement Monsanto Company (US) 1985-06-05 EP disclosed
US-4480130-A Preparation of ortho-(alkylthiomethyl) anilines by catalytic sulfilimine rearrangement MONSANTO COMPANY (US) 1984-10-30 US disclosed
EP-0039810-A1 Process for the preparation of 2-trifluoromethyl aniline BAYER AG (DE) 1981-11-18 EP disclosed
US-4008278-A FROM AN AMINO-BENZOTRIFLUORIDE AND A HALOGEN SOURCE OLIN CORPORATION (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240027309-A1 SIMPLE FIXATION AND STABILISATION EWSR1, FOSB, PAXBP1 POLB 214/4885MAPK1 4410/4885MEN1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.